In re Sun Healthcare Group, Inc.

214 F.R.D. 671, 2003 U.S. Dist. LEXIS 7116, 2003 WL 1957478
CourtDistrict Court, D. New Mexico
DecidedApril 21, 2003
DocketNos. CV-99-269MV/LCS-ACE, CV 99-319, CV 99-336, CV 99-349, CV 99-369, CV 99-418, CV 99-423, CV 99-424, CV 99-439, CV 99-459, CV 99-460, CV 99-478, CV 99-508
StatusPublished

This text of 214 F.R.D. 671 (In re Sun Healthcare Group, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Sun Healthcare Group, Inc., 214 F.R.D. 671, 2003 U.S. Dist. LEXIS 7116, 2003 WL 1957478 (D.N.M. 2003).

Opinion

MEMORANDUM OPINION AND ORDER

VAZQUEZ, District Judge.

THIS MATTER comes before the Court on Plaintiffs Motion to Amend the Judgment Dismissing This Action With Prejudice Pursuant to Fed.R.Civ.P. 59(e) and To Amend the Complaint Pursuant to Fed.R.Civ.P. 15(a) [Doc. No. 91]. The Court, having reviewed the motion, briefs, relevant law, and being otherwise fully advised, finds that the motion is not well-taken and will be DENIED.

BACKGROUND

Plaintiffs are a class of individuals who had acquired common stock of Sun Healthcare Group, Inc. (Sun), one of the largest full-service, long-term healthcare providers in the United States, between June 2, 1998 and February 1, 1999 (the Class Period). On September 10,1999, Plaintiffs filed a Consolidated Amended Complaint [Doc. No. 27] against several senior-level managers or directors of Sun, alleging violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder (Count I) and violations of Section 20 of the Exchange Act (Count II). In Count I, Plaintiffs alleged that Defendants Andrew L. Turner, Mark G. Wimer, and Robert D. Woltil, all executive officers of Sun, made or approved various materially false and misleading statements or omissions during the Class Period in press releases, interviews, statements to analysts [673]*673and SEC filings regarding the effect of the new federal health care legislation on Sun. Plaintiffs further allege that Defendant Wol-til, Sun’s Chief Financial Officer, signed materially false and misleading Form 10-Q financial reports and sold shares of Sun for over $90,000 while in possession of material, adverse, and undisclosed facts about the company. In Count II, Plaintiffs allege that Defendants are “controlling persons” as a result of their positions within Sun and, therefore, are subject to the control person liability provisions of Section 20 of the Exchange Act.

On December 5, 2000, Defendants filed a Motion to Dismiss the Consolidated Amended Complaint [Doc. No. 54 & 55] in accordance with Rules 9(b) and 12(b)(6) of the Federal Rules of Civil Procedure and the Private Securities Litigation Reform Act of 1995 (PSLRA), 15 U.S.C. § 78u-4. Plaintiffs’ Opposition to Defendants’ Motion to Dismiss [Doc. No. 62] was filed on February 2, 2001, and Defendants replied [Doc. No. 65] on March 9, 2001. This Court heard arguments on the motion on September 25, 2001, at which time it took the motion under advisement.

Thereafter, the Court granted Defendants’ motion to dismiss with prejudice. As to some of the allegedly false and misleading statements, the Court found that they were not actionable as a matter of law, because the statements were (a) protected by both the “safe harbor” provisions of the PSLRA and the judicial “bespeaks caution” doctrine, see In re Sun Healthcare, 181 F.Supp.2d 1283, 1287-91 (D.N.M.2002); (b) reflecting immaterial statements of corporate optimism and “mere puffing,” see id. at 1291-92; (e) made by third-parties without Defendants’ express or implied imprimatur, see id. at 1292-93; or (d) made outside the Class Period, see id. at 1293-94. As for those false and misleading statements that were actionable, the Court found that Plaintiffs’ Complaint failed to meet the pleading standards for scienter in a PSLRA securities fraud case, as articulated by the Tenth Circuit in City of Philadelphia v. Fleming, 264 F.3d 1245, 1259-60 (10th Cir.2001). Specifically, this Court found that Plaintiffs’ Complaint failed to “state with particularity facts giving rise to a strong inference,” 15 U.S.C. § 78u-4(b)(l)-(2), that Defendants had acted with “intent to deceive, manipulate, or defraud,” Fleming, 264 F.3d at 1259. See Sun Healthcare, 181 F.Supp.2d at 1294-98. Consistent with the ruling, a judgment against the Plaintiffs was filed on January 31, 2002.

On February 14, 2002, Plaintiffs filed the present motion, requesting that the ease be reopened pursuant to Rule 59(e) and that they be allowed to amend their complaint pursuant to Rule 15(a) of the Federal Rules of Civil Procedure. Plaintiffs contend that the proposed amended complaint (Amended Complaint) meets the pleading requirements set forth in Fleming and applied by this Court in its prior opinion. Defendants respond first that Plaintiffs have not shown that grounds for granting relief under Rule 59(e) exist and, second, that the proposed amendments do not remedy the fatal deficiencies of the Complaint.

STANDARD

A Rule 59(e) motion to amend judgment is basically a motion for reconsideration. See Servants of Paraclete v. Does, 204 F.3d 1005, 1012 (10th Cir.2000). The court may grant such a motion for one of three reasons: an intervening change in controlling law; availability of new evidence; or the need to correct clear error or prevent manifest injustice. See id. If a party is seeking to supplement its Rule 59(e) motion with “new evidence,” the party must show either that (a) the evidence is newly discovered, or (2) if the evidence was available when summary judgment was granted, that counsel made a diligent though unsuccessful attempt to discover the evidence. See Committee for First Amendment v. Campbell, 962 F.2d 1517, 1523 (10th Cir.1992). A motion to reconsider is not another opportunity for the losing party to make its strongest case, rehash arguments, or revamp previously unmeritorious arguments. See Voelkel v. Gen. [674]*674Motors Corp., 846 F.Supp. 1482, 1483 (D.Kan.1994), aff'd, 43 F.3d 1484 (10th Cir. 1994). The court should not grant a Rule 59(e) if the movant only wants to present new arguments or supporting facts that could have been offered initially. See Van Skiver v. United States, 952 F.2d 1241, 1243 (10th Cir. 1991). The decision to grant or deny such a motion is committed to the sound discretion of the trial court. See Hancock v. City of Okla. City, 857 F.2d 1394, 1395 (10th Cir.1988).

DISCUSSION

In their motion to amend, Plaintiffs make no mention of what the standard is for granting a Rule 59(e) motion, let alone discuss how this standard is met in their case. Plaintiffs make a single statement, in passing, that their “continuing investigation has uncovered specific information to bolster their allegations and they should be afforded the opportunity to amend their claims to include this new information” that can be read as addressing whether grounds for granting their motion exists. Plaintiffs’ motion instead focuses on whether this Court must grant leave to amend under Rule 15(a).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Servants of the Paraclete v. Does
204 F.3d 1005 (Tenth Circuit, 2000)
City of Philadelphia v. Fleming Companies, Inc.
264 F.3d 1245 (Tenth Circuit, 2001)
Elizabeth Werner v. Eric Werner
267 F.3d 288 (Third Circuit, 2001)
Voelkel v. General Motors Corp.
846 F. Supp. 1482 (D. Kansas, 1994)
In Re Sun Healthcare Group, Inc. Securities Litigation
181 F. Supp. 2d 1283 (D. New Mexico, 2002)
Webber v. Mefford
43 F.3d 1340 (Tenth Circuit, 1994)
Harris v. Illinois-California Express, Inc.
687 F.2d 1361 (Tenth Circuit, 1982)

Cite This Page — Counsel Stack

Bluebook (online)
214 F.R.D. 671, 2003 U.S. Dist. LEXIS 7116, 2003 WL 1957478, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-sun-healthcare-group-inc-nmd-2003.